These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23196941)

  • 1. Dramatic regression of three-vessel disease under statin treatment in patients with stable angina pectoris.
    Ercan S; Sari I; Davutoglu V
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):259-60. PubMed ID: 23196941
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins for treating stable angina: can statins improve the plaque morphology and angina?
    Lee CW; Park SJ
    Future Cardiol; 2013 Mar; 9(2):155-8. PubMed ID: 23463966
    [No Abstract]   [Full Text] [Related]  

  • 3. Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
    Burgstahler C; Reimann A; Beck T; Kuettner A; Heuschmid M; Kopp AF; Schroeder S
    Int J Cardiovasc Imaging; 2006 Feb; 22(1):119-21. PubMed ID: 16374526
    [No Abstract]   [Full Text] [Related]  

  • 4. Profound regression of coronary atherosclerosis with statins.
    Abdallah MH; Karrowni W; Dakik HA
    Can J Cardiol; 2006 Jun; 22(8):709. PubMed ID: 16802002
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study.
    Voros S; Joshi PH; Vazquez G; Roth G; Murrieta L; Rinehart S; Qian Z; Miller J
    J Cardiovasc Comput Tomogr; 2010; 4(3):164-72. PubMed ID: 20413364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study.
    Yokoyama M; Komiyama N; Courtney BK; Nakayama T; Namikawa S; Kuriyama N; Koizumi T; Nameki M; Fitzgerald PJ; Komuro I
    Am Heart J; 2005 Aug; 150(2):287. PubMed ID: 16086932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy for subclinical atherosclerosis in primary prevention: time to prove it?
    Villines TC
    JACC Cardiovasc Imaging; 2012 Mar; 5(3):261-3. PubMed ID: 22421170
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
    Iwata A; Miura S; Tanaka T; Ike A; Sugihara M; Nishikawa H; Kawamura A; Saku K
    Coron Artery Dis; 2012 Aug; 23(5):315-21. PubMed ID: 22617341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study.
    Mulders TA; Sivapalaratnam S; Stroes ES; Kastelein JJ; Guerci AD; Pinto-Sietsma SJ
    JACC Cardiovasc Imaging; 2012 Mar; 5(3):252-60. PubMed ID: 22421169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome.
    Uzun M; Yiğiner O; Kirilmaz A
    Turk Kardiyol Dern Ars; 2009 Jul; 37(5):364; author reply 365. PubMed ID: 19875919
    [No Abstract]   [Full Text] [Related]  

  • 11. Torcetrapib and atorvastatin.
    Shear CL
    N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16207861
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
    N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease.
    Wielepp P; Baller D; Gleichmann U; Pulawski E; Horstkotte D; Burchert W
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1371-7. PubMed ID: 16133398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin comparisons in controlled clinical trials.
    Citkowitz E
    Am J Cardiol; 2005 Nov; 96(10):1467-8. PubMed ID: 16275204
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
    Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DUAAL: atorvastatin provided an unexpectedly potent heart benefit in patients with chronic stable angina.
    Cardiovasc J Afr; 2008; 19(3):174. PubMed ID: 18568187
    [No Abstract]   [Full Text] [Related]  

  • 18. Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis.
    Clementi F; Di Luozzo M; Mango R; Luciani G; Trivisonno A; Pizzuto F; Martuscelli E; Mehta JL; Romeo F
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):231-7. PubMed ID: 19262209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting specific traditional risk factors to improve cardiovascular outcomes: Sound or flawed?
    Yeboah J
    Atherosclerosis; 2013 Feb; 226(2):335-6. PubMed ID: 23153621
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.